Vaccines Financial News

Subscribe to enjoy similar stories.New Delhi: India is planning to overhaul its pharmaceutical storage rules for vaccines and biological products, as gaps in the regulatory framework have frequently led to drugs being stored under improper temperature conditions, potentially compromising their efficacy, according to two government officials and documents reviewed by Mint.The plan is to define and classify these medications into two group— thermostable or those that can survive high temperatures, and thermolabile, or those that cannot, to ensure medicines, including insulin and vaccines are handled with scientific precision throughout the supply chain. Currently, the Drugs and Cosmetics Act, 1940, lacks these specific classifications.While Schedule P of the Drugs Rules, 1945 provides general storage instructions such as ‘cold place’ for temperatures not exceeding 8 degrees Celsius, there has been no comprehensive, science-based list to guide manufacturers and drug inspectors.

full Q4 earnings report by Jas Bardia.Inside Anthropic’s Project Glasswing: Can AI outsmart hackers before they strike? That’s the big idea that powers Anthropic’s Project Glasswing—a coalition using advanced AI to detect hidden software flaws even experts miss.With cyberattacks rising and a shortage of skilled professionals, this could be a game-changer. The AI can not only spot “zero-day” vulnerabilities but also suggest fixes, potentially transforming how cybersecurity works.

NEW DELHI: India plans to restrict the testing of vaccines and specialized biological products exclusively to government-controlled laboratories to maintain quality standards, according to two government officials and documents reviewed by Mint. This new approach will affect private laboratory operators and the pharmaceutical manufacturers that rely on them for faster testing turnaround times.Under the existing rules, private labs are allowed to test specified drugs including vaccines and biologicals.

Mint explains what we know so far about the new variant, and how concerned you should be.The latest variant is a part of the Omicron strain that swept across the globe in late 2021. It was first detected in 2024 in South Africa but had remained dormant until now, causing it to be dubbed ‘cicada’ (after the insect that remains underground for long periods before suddenly emerging).It has an unusually large number of mutations in its spike protein compared to LP.8.1, the strain used as the basis for the 2025-26 vaccines.

New Delhi: India has intensified its public health battle against tuberculosis (TB), a disease that the World Health Organization said officially reclaimed its position as the world’s leading infectious killer in 2023, surpassing covid-19. While the initial 2025 target set in the National Strategic Plan served as a catalyst for a 10-fold increase in funding to ₹6,356 crore in FY26 from ₹640 crore in 2015, India remains committed to eliminating the disease well ahead of the global 2030 deadline.To reach this goal, the government is leveraging artificial intelligence, community support, and rigorous airborne infection control.

Vetic, to name just three. These clinics epitomize a big shift that is playing out across urban India: the corporatization of veterinary services.Until a few years ago, India’s petcare market was a highly fragmented affair, dominated by neighbourhood pet stores, standalone vets and a handful of product brands.

NEW DELHI: Prime Minister Narendra Modi launched the nationwide Human Papillomavirus (HPV) vaccination campaign on 28 February by including it in India’s Universal Immunization Programme to vaccinate 12 million girls annually. With 120,000 new cases and 80,000 deaths annually, India accounts for a quarter of global cervical cancer deaths.Infection by certain HPV strains can cause precancerous cell changes, which may eventually lead to cancer.Mint explains the rationale behind the plan to help stop cervical cancer – the second most common cancer among women in India – by leveraging the country's digital infrastructure and primary health centre network.The aim is to prevent cervical cancer in girls before they are exposed to the virus.

Mint first reported that IndiaRF has mandated Rothschild to help scout for buyers for the portfolio company that is seeking a valuation of about $1 billion.The stake sale underscores rising investor appetite for scaled API platforms with export-heavy books, especially as India’s pharma supply chain strengthens its position in regulated markets and private equity firms seek pre-IPO opportunities in defensible healthcare assets.“The exact amount of the ongoing fundraise is contingent to an acquisition that Synthimed is evaluating,” a third person said. “If the acquisition goes as planned, the round may potentially become larger with a primary capital infusion.

Subscribe to enjoy similar stories. NEW DELHI: India plans to centralize testing and quality control of 42 essential veterinary vaccines at a single national laboratory, replacing a fragmented system that allows self-certification and state-level testing, according to two government officials and a document reviewed by Mint.

Subscribe to enjoy similar stories. Bengaluru/Mumbai: India’s HPV vaccine market is seeing a clear revival after years of low uptake, with digital health platforms and private healthcare providers reporting a sharp rise in demand amid growing awareness of cervical cancer prevention. On PharmEasy, a digital-first diagnostics and pharmacy company backed by Prosus and Temasek, HPV vaccines now account for nearly 25% of total vaccine sales, making it one of the fastest-growing segments within its preventive healthcare portfolio.

Subscribe to enjoy similar stories. New Delhi: India’s drug regulator has signalled zero-tolerance for polio-related risk, turning down a proposal by National Dairy Development Board's (NDDB) subsidiary Indian Immunologicals Ltd (IIL) to start human trials of its ‘six-in-one’ paediatric vaccine over concerns it could undermine the country’s polio-free status, according to two government officials and documents reviewed by Mint.

Subscribe to enjoy similar stories. India is preparing a national funding offensive to tackle a burgeoning stray dog crisis, as a surge in attacks and rabies fatalities forces the government to intervene in a long-standing public health failure. The Union budget may propose a scheme to finance the mass sterilization of stray dogs at government veterinary hospitals, three officials familiar with the matter said.

Subscribe to enjoy similar stories. India has a habit of approaching big technological questions in refreshingly practical ways. We adopt new ideas when they solve real problems, fit our context and prove themselves through evidence—not because the rest of the world is excited about them.

Subscribe to enjoy similar stories. India launched a surveillance drive following the identification of two suspected cases of Nipah virus (NiV) in West Bengal on 11 January. With two patients—both nurses—under observation at the All India Institute of Medical Sciences (AIIMS) at Kalyani in West Bengal, the Central government has activated the Public Health Emergency Operations Centre (PHEOC) in New Delhi.

Subscribe to enjoy similar stories. India plans to get its drug regulatory system audited and rated by the World Health Organization (WHO) to detect specific strengths and weaknesses that will help to make it fool proof, according to four officials and a document reviewed by Mint. The move comes after multiple instances of drug safety related incidents in the country as well as export markets raised serious questions on the quality of medicines made in India, often referred to as ‘pharmacy of the world’.

Subscribe to enjoy similar stories. NEW DELHI : India is witnessing a significant surge in influenza cases, driven by the H3N2 subtype, clinically known to cause more severe infections and higher hospitalizations, according to the latest surveillance data from the country's premier medical research organization, the Indian Council of Medical Research (ICMR). Taking cognisance of the situation, Union health minister J.P.

Subscribe to enjoy similar stories. What do the following three companies have in common? Stellantis, owner of the Fiat, Jeep and Chrysler brands; Merck, which makes the world’s bestselling cancer drug; and Barry Callebaut, a Swiss chocolate-maker, which is particularly proud of its ruby flavour, neither sweet nor bitter. One answer: their capital-expenditure (capex) plans.

Subscribe to enjoy similar stories. Despite being among the great scientific breakthroughs of all time, vaccines are under fire as top government officials cast doubts on their safety. But as doctors and vaccine deniers spar over the safety of vaccines, emerging evidence finds that some vaccines aren’t only good at preventing the disease or virus they target but also might have broader or even unrelated health benefits.

Subscribe to enjoy similar stories. NEW DELHI: India’s drug regulator, the Drugs Controller General of India (DCGI), plans to tighten rules on the sale and distribution of emergency contraceptive pills, including levonorgestrel formulations, sold under brand names such as Unwanted-72 and i-pill, and ulipristal pills sold as ella. The move, aimed at preventing habitual overuse and ensuring women have access to critical safety information, will require these pills to carry QR codes on their packaging, according to two officials and a document reviewed by Mint.

Subscribe to enjoy similar stories. One of the greatest public-health achievements of recent decades has been driving down child mortality around the world. Now, that long-running decline is reversing.

Subscribe to enjoy similar stories. Born into privilege as a princess in the 1900s in India, Amrit Kaur could have led a life of comfort and quiet influence. Instead, she used her station to steer some of independent India’s most vital reforms.